Austal USA is exploring opportunities in European markets for its recently developed medical ship, designed for the US Navy. The company aims to increase future production to prevent downtime at its facilities.
Larry Ryder, an executive at Austal, stated to Breaking Defense at the Euronaval exposition, “We’re interested in expanding our market — looking ahead three to four years — as we want to explore a new set of programs. This is a market segment we haven’t tapped yet. We’ve almost secured a few international foreign military sales deals, but we want to assess the market here.”
Austal plans to construct three Bethesda-class Expeditionary Medical Ships for the US Navy, which are specialized vessels derived from the expeditionary fast transports. These ships offer a more agile version of the traditional hospital ships, Comfort and Mercy.
The push to introduce this platform in international markets is informed by Austal’s recent challenges. As reported by Breaking Defense, the company’s shipyard in Mobile, Alabama, faced significant program closures and layoffs early in the COVID-19 pandemic when several US Navy programs were nearing completion, leaving no new projects in the pipeline.
By expanding its facilities and securing new contracts, the shipyard—known for being a key builder for the US Navy—has emerged from that challenging period with a more varied portfolio than before. Ryder emphasized the importance of proactive market engagement: “We need to be looking three to four years ahead, and if we wait until we’re in need of work, it’s too late.”
Europe presents new opportunities for Austal, as the Expeditionary Medical Ship is a product of Austal USA, while its parent company in Australia primarily focuses on its domestic market and Asia, especially regarding defense initiatives.
